Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Ishikawa

Showing results (81-90 of 181) with videos related to

Pageof 19
Sort By:
Blood Cell Therapy|December 26, 2023
Gilteritinib in peritransplant period for relapsed or refractory FLT3-mutated acute myeloid leukemia: A case report of three patientsFuka Mima, Shigeo Fuji, Kumi Shibata, et al.
Arthritis Research & Therapy|June 9, 2016
Soluble Siglec-9 suppresses arthritis in a collagen-induced arthritis mouse model and inhibits M1 activation of RAW264.7 macrophagesTakuya Matsumoto, Nobunori Takahashi, Toshihisa Kojima, et al.
International Journal of Hematology|July 5, 2003
Localized relapse in bone marrow in a posttransplantation patient with t(6;9) acute myeloid leukemiaTetsuo Maeda, Satoru Kosugi, Hidetoshi Ujiie, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2012
Successful treatment of duodenal myeloid sarcoma with allogeneic bone marrow transplantation and additional radiotherapyToshinari Yagi, Jun Ishikawa, Masahumi Takahashi, et al.
Scientific Reports|October 13, 2018
Insight into the draft whole-genome sequence of the dermatophyte Arthroderma vanbreuseghemiiMohamed Mahdi Alshahni, Tsuyoshi Yamada, Ayaka Yo, et al.
Scientific Reports|July 2, 2025
A comparative study of GVHD prophylaxis using low dose ATG versus PTCy for PBSCT based on two independent prospective cohortsSouichi Shiratori, Junichi Sugita, Jun Ishikawa, et al.
Bone Marrow Transplantation|December 19, 2023
Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donorJunichi Sugita, Takashi Kuroha, Jun Ishikawa, et al.
Blood Cell Therapy|June 21, 2023
A case of severe oral mucosal GVHD induced by heterologous SARS-CoV-2 vaccination after cord blood transplantationKazuhiro Sanda, Shigeo Fuji, Hidetoshi Satomi, et al.
Molecular Pharmacology|January 13, 2006
A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activityRyuichi Takezawa, Henrique Cheng, Andreas Beck, et al.
Bioorganic & Medicinal Chemistry|October 7, 2008
Novel potent and selective Ca2+ release-activated Ca2+ (CRAC) channel inhibitors. Part 3: synthesis and CRAC channel inhibitory activity of 4'-[(trifluoromethyl)pyrazol-1-yl]carboxanilidesYasuhiro Yonetoku, Hirokazu Kubota, Yoji Miyazaki, et al.
Pageof 19

Showing results (81-90 of 181) with videos related to

Sort By:
Pageof 19
Blood Cell Therapy|December 26, 2023
Gilteritinib in peritransplant period for relapsed or refractory FLT3-mutated acute myeloid leukemia: A case report of three patientsFuka Mima, Shigeo Fuji, Kumi Shibata, et al.
Arthritis Research & Therapy|June 9, 2016
Soluble Siglec-9 suppresses arthritis in a collagen-induced arthritis mouse model and inhibits M1 activation of RAW264.7 macrophagesTakuya Matsumoto, Nobunori Takahashi, Toshihisa Kojima, et al.
International Journal of Hematology|July 5, 2003
Localized relapse in bone marrow in a posttransplantation patient with t(6;9) acute myeloid leukemiaTetsuo Maeda, Satoru Kosugi, Hidetoshi Ujiie, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2012
Successful treatment of duodenal myeloid sarcoma with allogeneic bone marrow transplantation and additional radiotherapyToshinari Yagi, Jun Ishikawa, Masahumi Takahashi, et al.
Scientific Reports|October 13, 2018
Insight into the draft whole-genome sequence of the dermatophyte Arthroderma vanbreuseghemiiMohamed Mahdi Alshahni, Tsuyoshi Yamada, Ayaka Yo, et al.
Scientific Reports|July 2, 2025
A comparative study of GVHD prophylaxis using low dose ATG versus PTCy for PBSCT based on two independent prospective cohortsSouichi Shiratori, Junichi Sugita, Jun Ishikawa, et al.
Bone Marrow Transplantation|December 19, 2023
Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donorJunichi Sugita, Takashi Kuroha, Jun Ishikawa, et al.
Blood Cell Therapy|June 21, 2023
A case of severe oral mucosal GVHD induced by heterologous SARS-CoV-2 vaccination after cord blood transplantationKazuhiro Sanda, Shigeo Fuji, Hidetoshi Satomi, et al.
Molecular Pharmacology|January 13, 2006
A pyrazole derivative potently inhibits lymphocyte Ca2+ influx and cytokine production by facilitating transient receptor potential melastatin 4 channel activityRyuichi Takezawa, Henrique Cheng, Andreas Beck, et al.
Bioorganic & Medicinal Chemistry|October 7, 2008
Novel potent and selective Ca2+ release-activated Ca2+ (CRAC) channel inhibitors. Part 3: synthesis and CRAC channel inhibitory activity of 4'-[(trifluoromethyl)pyrazol-1-yl]carboxanilidesYasuhiro Yonetoku, Hirokazu Kubota, Yoji Miyazaki, et al.
Pageof 19